Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Queensland Health
US Department of Justice
Daiichi Sankyo
Covington
Dow
Teva
McKesson
AstraZeneca

Generated: January 24, 2018

DrugPatentWatch Database Preview

CARBIDOPA; LEVODOPA - Generic Drug Details

« Back to Dashboard

What are the generic sources for carbidopa; levodopa and what is the scope of carbidopa; levodopa freedom to operate?

Carbidopa; levodopa
is the generic ingredient in seven branded drugs marketed by Impax Labs Inc, Abbvie Inc, Accord Hlthcare, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Merck Sharp Dohme, Ranbaxy, Sun Pharma Global, Ucb Inc, Actavis Elizabeth, Apotex Inc, Idt Australia Ltd, Mayne Pharma, SCS, and Watson Labs, and is included in twenty-nine NDAs. There are eight patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Carbidopa; levodopa has thirty-five patent family members in fourteen countries.

There are eighteen drug master file entries for carbidopa; levodopa. Thirty-two suppliers are listed for this compound.
Summary for CARBIDOPA; LEVODOPA
International Patents:35
US Patents:8
Tradenames:7
Applicants:18
NDAs:29
Drug Master File Entries: 18
Suppliers / Packagers: 32
Clinical Trials: 342
Drug Prices:see low prices
DailyMed Link:CARBIDOPA; LEVODOPA at DailyMed
Pharmacology for CARBIDOPA; LEVODOPA

US Patents and Regulatory Information for CARBIDOPA; LEVODOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy CARBILEV carbidopa; levodopa TABLET, FOR SUSPENSION;ORAL 076643-001 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 078536-001 Oct 28, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074260-003 Sep 3, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-003 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-002 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Idt Australia Ltd CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073587-003 Jun 29, 1995 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-002 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Ranbaxy CARBILEV carbidopa; levodopa TABLET, FOR SUSPENSION;ORAL 076643-002 Jun 10, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-003 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-002 Jan 7, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CARBIDOPA; LEVODOPA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-002 Dec 24, 1992 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for CARBIDOPA; LEVODOPA

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Cerilliant
AstraZeneca
Cipla
McKinsey
Novartis
Cantor Fitzgerald
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot